1-4 of 4
Nicola Hardwick
Close
Sort by
Journal Articles

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults

Clinical Trials & Observations
Corinna La Rosa, Jeff Longmate, Joy Martinez, Qiao Zhou, Teodora I. Kaltcheva, Weimin Tsai, Jennifer Drake, Mary Carroll, Felix Wussow, Flavia Chiuppesi, Nicola Hardwick, Sanjeet Dadwal, Ibrahim Aldoss, Ryotaro Nakamura, John A. Zaia, Don J. Diamond
Journal: Blood
Blood (2017) 129 (1): 114–125.
https://doi.org/10.1182/blood-2016-07-729756
Published: 2017
Includes: Supplemental data
Journal Articles

RFUSIN2 - a Clinical Grade Lentiviral Vector Co-Expressing CD80/IL-2 Manufactured Under GMP for a Phase I Clinical Trial Study of Immune Gene Therapy for Poor Prognosis Acute Myeloid Leukaemia

Lucas Chan, Wendy Ingram, Nicola Hardwick, David Darling, Joti Bhalla, Aytug Kizilors, Shahram Y Kordasti, Ghulam J Mufti, Farzin Farzaneh
Journal: Blood
Blood (2008) 112 (11): 4630.
https://doi.org/10.1182/blood.V112.11.4630.4630
Published: 2008
Journal Articles

In-Vitro Culture of Human CD80/IL2 Lentivirus Transduced Acute Myeloid Leukemia Cells (AML) Promote NK Cell Activation and Cytolytic Activity

Wendy Ingram, Lucas Chan, Hayrettin Guven, Shahram Kordasti, Linda Barber, Nicola Hardwick, David Darling, Ghulam J Mufti, Farzin Farzaneh
Journal: Blood
Blood (2008) 112 (11): 2969.
https://doi.org/10.1182/blood.V112.11.2969.2969
Published: 2008
Journal Articles

IL-2/B7.1 Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: A Strategy To Generate Whole Cell Vaccines for AML.

Lucas Chan, PhD, Nicola Hardwick, MPhil, Dave Darling, PhD, Joanna Galea-Lauri, PhD, Joop Gäken, PhD, Stephen Devereux, MD PhD, Mike Kemeny, PhD FRCPath, Ghulam Mufti, MD PhD DSc FRCP, Farzin Farzaneh, DPhil FRCPath
Journal: Blood
Blood (2004) 104 (11): 5275.
https://doi.org/10.1182/blood.V104.11.5275.5275
Published: 2004